Skip to content

Brandon Capital

Brandon Capital is a leading life science venture capital firm based in Australasia, focusing on transforming medical research breakthroughs into therapies. It has a strong global presence with partnerships in the US and UK.

Recorded stages
Seed, Seed Plus, Series A, Series B, Growth Equity
Recorded regions
Global, United Kingdom, United States

Online destinations

Find Brandon Capital online

Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.

Official links

Pages the organization runs itself.

Overview

Brandon Capital is a life science venture capital firm based in Australasia, with a global presence supported by partnerships in the United States and the United Kingdom. The firm focuses on transforming medical research breakthroughs into therapies that improve patient outcomes. Founded to support life science companies from early-stage seed investment through to expansion capital, Brandon Capital primarily operates in Australia and New Zealand. The firm invests in various sectors, including oncology, neuroscience, cardiovascular, and digital health, collaborating with medical research institutes to create investment opportunities.

Focus

Brandon Capital invests in life science companies, particularly in biotechnology and pharmaceuticals. The firm supports companies at various stages, from proof-of-concept to commercialization, with a focus on oncology, neuroscience, cardiovascular, and digital health sectors. Their investment strategy is bolstered by collaborations with medical research institutes and hospitals to source and create investment opportunities.

Support

Brandon Capital adds value to its portfolio companies through its unique Brandon BioCatalyst initiative, which collaborates with over 50 medical research institutions to support the development and commercialization of early-stage biomedical discoveries. This network provides proprietary deal flow and access to critical resources for portfolio companies.

Questions

What are Brandon Capital's investment criteria?

Brandon Capital focuses on life science companies, particularly in biotechnology and pharmaceuticals, investing at various stages from seed to expansion capital.

How can startups apply or pitch to Brandon Capital?

Startups can pitch to Brandon Capital through their website at brandoncapital.vc or by emailing info@brandoncapital.com.au.

What makes Brandon Capital different from other venture capital firms?

Brandon Capital's unique Brandon BioCatalyst initiative collaborates with over 50 medical research institutions, providing proprietary deal flow and access to critical resources for portfolio companies.

What is the geographic scope of Brandon Capital's investments?

Brandon Capital invests in companies across North America, Europe, Asia, Oceania, and specifically Australia and New Zealand.

What is the typical check size for investments?

Brandon Capital typically invests between $500,000 and $10 million in their portfolio companies.

Check your startup’s fit

Check your startup’s fit with Brandon Capital

Similar investors

Organizations that do similar work to Brandon Capital.

All investors
o2h group logoInvestor

Investing in the future of life sciences and technology.

HUMAN CAPITAL logoInvestor

Human Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.

OrbiMed logoInvestor

OrbiMed is a healthcare-focused investment firm based in New York City, managing approximately $19 billion in assets. The firm invests across the healthcare spectrum, from early-stage startups to large multinational companies, with a focus on biopharmaceuticals and medical technologies.

SV Health Investors logoInvestor

SV Health Investors is a healthcare-focused venture capital and growth equity firm based in Boston and London. With over 30 years of experience, it specializes in investing across various healthcare sectors, including biotechnology and medtech.

Superscout Pro

Find faster. Show up verified. Keep your deals private.

$99a year, or $12 a month
Get Pro

Is this page right?Reviewed · How the research works

Something's off